Salvage Second Hematopoietic Cell Transplantation in Myeloma

Autologous hematopoietic cell transplantation (AHCT) as initial therapy of patients with multiple myeloma (MM) improves survival. However, data to support this approach for relapsed/progressive disease after initial AHCT (AHCT1) are limited. Using Center for International Blood and Marrow Transplant...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Michaelis, Laura C., Saad, Ayman, Zhong, Xiaobo, Le-Rademacher, Jennifer, Freytes, Cesar O., Marks, David I., Lazarus, Hillard M., Bird, Jennifer M., Holmberg, Leona, Kamble, Rammurti T., Kumar, Shaji, Lill, Michael, Meehan, Kenneth R., Saber, Wael, Schriber, Jeffrey, Tay, Jason, Vogl, Dan T., Wirk, Baldeep, Savani, Bipin N., Gale, Robert P., Vesole, David H., Schiller, Gary J., Abidi, Muneer, Anderson, Kenneth C., Nishihori, Taiga, Kalaycio, Matt E., Vose, Julie M., Moreb, Jan S., Drobyski, William, Munker, Reinhold, Roy, Vivek, Ghobadi, Armin, Holland, H. Kent, Nath, Rajneesh, To, L. Bik, Maiolino, Angelo, Kassim, Adetola A., Giralt, Sergio A., Landau, Heather, Schouten, Harry C., Maziarz, Richard T., Mikhael, Joseph, Kindwall-Keller, Tamila, Stiff, Patrick J., Gibson, John, Lonial, Sagar, Krishnan, Amrita, Dispenzieri, Angela, Hari, Parameswaran
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3816739/
https://ncbi.nlm.nih.gov/pubmed/23298856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2013.01.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars